MedTech: The Business of Medical Devices to Draw Hundreds of Entrepreneurs to Learn From and Network With Investors and the Best Minds in Medical Device Technologies
ANN ARBOR, Mich., 03/08/2004 -- The Samuel Zell and Robert H. Lurie Institute for Entrepreneurial Studies, the world's leading university-based center for entrepreneurial studies, will present its fourth annual emerging industry symposium, titled MedTech: The Business of Medical Devices. Co-sponsored by the Office of Technology Transfer, the free event will feature internationally-regarded analysts and investors leading discussions on the best business models and funding opportunities for emerging companies in the medical device industry.
From replacement hips to dialysis machines, tens of millions of Americans are touched by medical devices each and every day. The symposium will explore the economic forces that come into play as these new, non-pharmaceutical medical technologies strive to reach the marketplace. Attendees will be able to speak directly with Michigan-based researchers and Medical Device companies during the poster session immediately following the panel discussion.
"Our annual symposium provides invaluable insight into successful business models and funding strategies employed in emerging industries such as medical devices," said Thomas Kinnear, executive director of the Zell Lurie Institute for Entrepreneurial Studies. "We're bringing the talent and ideas of innovative startups and prominent venture capitalists to an event designed to give emerging entrepreneurs in this industry the means to successfully strategize and grow their company."
The Symposium will feature two industry leading keynote speakers: Thomas J. Gunderson, Senior Research Analyst at Piper Jaffray, who will speak on "Trends and Forces Influencing the Marketplace," and Stephen N. Oesterle, M.D., Senior Vice President for Medicine and Technology at Medtronic, who will discuss "The Future of MedTech." Two panel discussions are also included in this event, "Business Models, Strategies and Partnerships" and "The Partnering Perspective from Michigan Biotech Start-Up Companies." A poster session encouraging entrepreneurs to network directly with Michigan-based medical device companies and researchers wraps up the event.
The Symposium will be held at the Crown Plaza Hotel in Ann Arbor, Friday, March 12, 2004 from 7:30 a.m. â€" 1:00 p.m. Registration is free. For further information or to register, please visit www.zli.bus.umich.edu and click on March 12: MedTech Symposium.
About Samuel Zell and Robert H. Lurie Institute for Entrepreneurial Studies
The Samuel Zell & Robert H. Lurie Institute for Entrepreneurial Studies was formed in October 1999. The Institute actively engages the nation's most successful entrepreneurs and offers an outstanding faculty composed of both academic researchers and practitioners in entrepreneurship. The Institute's mission is to focus the capabilities and resources of the University of Michigan Business School to provide education, experience and opportunities in entrepreneurship; serve as a catalyst for new venture development; and contribute important research in the field of entrepreneurship. Members of the Institute's Advisory Board include Samuel Zell, Chairman of Equity Group Investments; Michael Hallman, former COO of Microsoft Corporation; and Eugene Applebaum, Founder of Arbor Drugs.
###
<< Venture Capital Contest |
University of Michigan Press Releases |
Student Start-Up Grants >>
page 3 of 14 |
|
